Browsing by Author Fulcher, Greg

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 40 of 65 < previous   next >
Issue DateTitleAuthor(s)Citation
2009The effects of fenofibrate treatment on cardiovascular disease risk in 9795 people with type 2 diabetes and various components of the metabolic syndrome: the FIELD study.Fulcher, Greg; Keech, Anthony (Tony); Pardy, Christopher; Tse, D; D'Emden, Michael C.; Ehnholm, Christian; FIELD study investigators, Fenofibrate Intervention and Event Lowering in Diabetes; O'Brien, Richard; Scott, Russell; Taskinen, M.; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreThe effects of fenofibrate treatment on cardiovascular disease risk in 9795 people with type 2 diabetes and various components of the metabolic syndrome: the FIELD study., Diabetes Care, vol.32,(3),2009,pp 493-498
2017Effects of sotagliflozin added to insulin in patients with type 1 diabetesFulcher, Greg; Banks, Phillip; Buse, John B.; Danne, Thomas; Davies, Melanie; Garg, Satish K.; Gesty-Palmer, Diane; Henry, Robert R.; Kushner, Jake A.; Lapuerta, Pablo; Mcguire, Darren K; Peters, Anne; Pozzilli, Paolo; Simo, Raphael; Strumph, Paul; Northern Clinical School: MedicineEffects of sotagliflozin added to insulin in patients with type 1 diabetes, New England Journal of Medicine, vol.377, 24, 2017,pp 2337-2348
2013Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trialAdams, Mark; Anderson, Craig; Arima, Hisatomi; Chalmers, John; Fulcher, Greg; Hata, Jun; Joshi, Rohina; Kengne, Andre; Neal, Bruce; Ninomiya, Toshiharu; Patel, Anushka; Pollock, Carol; Watson, John; Woodward, Mark; Zoungas, Sophia; Mancia, Giuseppe; Poulter, Neil; Central Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; The George Institute for Global Health; Northern Clinical School: Medicine; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global HealthEffects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial, PLoS One, vol.8, 2, 2013,pp 1-7
2015Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled TrialFulcher, Greg; Neal, Bruce; Perkovic, Vlado; Capuano, George; de Zeeuw, Dick; Desai, Mehul; Mahaffey, Kenneth W; Matthews, David. R.; Meininger, G; Rosenstock, Julio; Shaw, Wayne; Vercruysse, Frank; Weiss, Robert; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global HealthEfficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial, Diabetes Therapy, vol.6, 3, 2015,pp 289-302
2016Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetesFulcher, Greg; Neal, Bruce; Perkovic, Vlado; Capuano, George; de Zeeuw, Dick; Desai, Mehul; Mahaffey, Kenneth W; Mathieu, Chantal; Matthews, David. R.; Meininger, G; Shaw, Wayne; Vercruysse, Frank; Woo, Vincent; Wysham, C; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global HealthEfficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes, Diabetes, Obesity and Metabolism, vol.18, 1, 2016,pp 82-91
2015Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 DiabetesFulcher, Greg; Neal, Bruce; Perkovic, Vlado; Alba, Maria; Capuano, George; de Zeeuw, Dick; Desai, Mehul; Jiang, Joel; Mahaffey, Kenneth W; Matthews, David; Meininger, G; Shaw, Wayne; Vercruysse, Frank; Ways, Kirk; Northern Clinical School: Medicine; The George Institute for Global Health; The George Institute for Global HealthEfficacy and Safety of Canagliflozin, an Inhibitor of Sodium Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes, Diabetes Care, vol.38, 3, 2015,pp 403-411
2016Evaluation of Blood Glucose Meter Efficacy in an Antenatal Diabetes ClinicFulcher, Greg; Glastras, Sarah; Hocking, Samantha; McGrath, Rachael; Preda, Veronica; Donnelly, Vanessa; Sheriff, Nisa; Ward, Peter; Northern Clinical School: Medicine; Children's Hospital Westmead: Childrens Medical Research Ins; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: MedicineEvaluation of Blood Glucose Meter Efficacy in an Antenatal Diabetes Clinic, Diabetes Technology and Therapeutics, vol.18, 2, 2016,pp 68-74
2005An evidence based clinical aid for cardiovascular disease--what do GPs think?Fulcher, Greg; Keech, Anthony (Tony); Neale, Michael; Pollock, Carol; Amerena, John V.; Beltrame, John F; Conner, Greg W; et, al; Hankey, Graeme J.; Lloyd, Brian; McAvoy, Brian R; Sudhir, Krishna; Waltham, Robert D.; West, Malcolm J; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: Surgery; Northern Clinical School: MedicineAn evidence based clinical aid for cardiovascular disease--what do GPs think?, Australian Family Physician, vol.34,(4),2005,pp 297-298
2017Gaps and barriers in health-care provision for co-morbid diabetes and chronic kidney disease: a cross-sectional studyFulcher, Greg; Gallagher, Martin; Kerr, Peter G; Lo, Clement; Ranasinha, Sanjeeva; Russell, Grant; Teede, Helena J; Walker, Rowan G; Zoungas, Sophia; Northern Clinical School: Medicine; Concord Clinical School: MedicineGaps and barriers in health-care provision for co-morbid diabetes and chronic kidney disease: a cross-sectional study, BMC Nephrology, vol.18, 1, 2017,pp 1-10
2005Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.Fulcher, Greg; Yue, Dennis; Gilbert, R. E.; Northern Clinical School: Medicine; Central Clinical School: MedicineGlargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy., Internal Medicine Journal 2005, vol.35,(9),2005,pp 536-542
2015Healthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in AustraliaCraig, Maria; Fulcher, Greg; Holmes-Walker, Jane; Jenkins, Alicia; Alexander, Kristine S; Bryant, W K; Cohen, Neale D; et al, Various; Forbes, Melissa D L; Greenaway, Timothy M; Harrison, N; Howard, George; Jackson, Jonathan A; Kamp, M; Xu, S; Childrens Hospital Westmead: Paediatrics & Child Health; Northern Clinical School: Medicine; Western Clinical School: Medicine (Westmead); NH&MRC Clinical Trials CentreHealthcare professional requirements for the care of adult diabetes patients managed with insulin pumps in Australia, Internal Medicine Journal, vol.45, 1, 2015,pp 86-93
2007Hematologic and Urinary Excretion Anomalies in Patients with Chronic Fatigue SyndromeClifton-Bligh, Phillip; Dunsmore, Julie; Fulcher, Greg; Klineberg, Iven John; Butt, Henry L; Dunstan, Hugh; Hoskin, Leigh A.; King, Katrina E.; McGregor, Neil R; Niblett, Suzanne; Roberts, Timothy K.; Rothkirch, T. B.; Northern Clinical School: Medicine; Endo & Diabts Rsrch Fndt; Northern Clinical School: Medicine; Dentistry FacultyHematologic and Urinary Excretion Anomalies in Patients with Chronic Fatigue Syndrome, Experimental Biology and Medicine, vol.232, 8, 2007,pp 1041-1049
2017Identification of patients with diabetes who benefit most from a health coaching program in chronic disease Management, Sydney, Australia, 2013Fulcher, Greg; Glastras, Sarah; Hocking, Samantha; McGrath, Rachel; Delaney, Grace; Newlyn, N; Pamplona, E; Northern Clinical School: Medicine; Northern Clinical School: General Practice; Northern Clinical School: Medicine; Northern Clinical School: MedicineIdentification of patients with diabetes who benefit most from a health coaching program in chronic disease Management, Sydney, Australia, 2013, Preventing Chronic Disease, vol.14, E21, 2017,pp 1-8
2011Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trialDonoghoe, Mark; Fulcher, Greg; Keech, Anthony (Tony); Pardy, Christopher; Colman, P. G.; Davis, T. M. E.; Manning, Patrick; O'Brien, Richard; Scott, Russell; Taskinen, M.; Watts, Gerald F.; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreImpact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial, Cardiovascular Diabetology, vol.10, 1, 2011,pp 102-1-102-8
2016Impact of obesity and epicardial fat on early left atrial dysfunction assessed by cardiac MRI strain analysisBroadhouse, Kathryn; Callaghan, Fraser; Evin, Morgane; Figtree, Gemma Alexandra; Fulcher, Greg; Glastras, Sarah; Grieve, Stuart; Kozor, Rebecca; McGrath, Rachel; Hocking, Samantha L; Kachenoura, Nadjia; Lamy, Jerome; Redheuil, Alban; Central Clinical School: Medicine; Central Clinical School: Imaging; Central Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Children's Hospital Westmead: Childrens Medical Research Ins; Central Clinical School: Medicine; Northern Clinical School: Kolling Institute; Northern Clinical School: MedicineImpact of obesity and epicardial fat on early left atrial dysfunction assessed by cardiac MRI strain analysis, Cardiovascular Diabetology, vol.15, 1, 2016,pp 1-10
2015Insulin degludec and insulin aspart: novel insulins for the management of diabetes mellitusFulcher, Greg; Atkin, Stephen; Javed, Zeeshan; Northern Clinical School: MedicineInsulin degludec and insulin aspart: novel insulins for the management of diabetes mellitus, Therapeutic Advances in Chronic Diseases, vol.6, 6, 2015,pp 375-388
2011Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial.Fulcher, Greg; Endahl, Lars; Johansen, Thue; Lewin, Andrew; Lindh, Rebecca; Mathieu, Chantal; Pinget, Michel; Rao, Paturi; Rosenstock, Julio; Thomas, Nihal; Zinman, Bernard; Northern Clinical School: MedicineInsulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial., The Lancet, vol.377, 9769, 2011,pp 924-931
2010Insulin Intensification for People with Type 2 Diabetes: A Practical ApproachColagiuri, Stephen; Fulcher, Greg; Twigg, Stephen; Dalton, Brad; Phillips, Patrick; Prins, Johannes; Sinha, Ashim; Central Clinical School: Medicine; Northern Clinical School: Medicine; Central Clinical School: MedicineInsulin Intensification for People with Type 2 Diabetes: A Practical Approach, The Australasian Medical Journal, vol.3, 12,pp 808-813
2004Intravenous Pamidronate In The Treatment And Prevention Of Osteoporosis.Chan, San; Clifton-Bligh, Phillip; Fulcher, Greg; Gunton, Jenny; McElduff, Aidan; Nery, L. M.; Robinson, Bruce; Stiel, J. N.; Wilmshurst, E. G.; School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: Medicine; Northern Clinical School: Medicine; School of Molecular Bioscience; Northern Clinical School: Medicine; Central Clinical School: Department of Endocrinology at RPAH; Northern Clinical School: Medicine; Central Clinical School: Department of Endocrinology at RPAH; Central Clinical School: Department of Endocrinology at RPAHIntravenous Pamidronate In The Treatment And Prevention Of Osteoporosis., Internal Medicine Journal (Print), vol.34,(4),2004,pp 162-166
2005Leukocyte matrix metalloproteinase-9 is elevated and contributes to lymphocyte activation in type I diabetesClifton-Bligh, Roderick; Fulcher, Greg; Gallery, Eileen; Jackson, Christopher; Thompson, Patrick; Xue, Meilang; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: MedicineLeukocyte matrix metalloproteinase-9 is elevated and contributes to lymphocyte activation in type I diabetes, The International Journal of Biochemistry & Cell Biology, vol.37,(11),2005,pp 2406-2416